IntelligentMDx to Present CE-Marked Flu A/B and RSV Assay at ECCMID
4/25/2013 12:12:25 PM
More...
|
IntelligentMDx Announces CE-Marking of a Test for Detection and Differentiation of Influenza A, Influenza B, and Respiratory Syncytial Virus
4/12/2013 8:40:32 AM
More...
|
IntelligentMDx Enters into an Agreement With QIAGEN Inc. (QGEN) to Develop Molecular Tests
1/8/2013 9:23:12 AM
More...
|
IntelligentMDx Names Maurice Exner, Ph.D. Vice President of Research and Development
12/19/2012 2:45:50 PM
More...
|
IntelligentMDx to Present Development and Performance Data of 4 Infectious Disease Diagnostic Tests at AMP 2012 Annual Meeting
10/22/2012 9:52:29 AM
More...
|
IntelligentMDx to Present Development of Fully Automated Diagnostics for HSV-1/2 and Influenza A/B and RSV at the 15th Annual European Society for Clinical Virology Meeting
8/31/2012 10:27:58 AM
More...
|
IntelligentMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2
7/19/2012 1:47:11 PM
More...
|
IntelligentMDx Announces CE-Marking of a New High-throughput Test for Group B Streptococcus Intended to Improve Women's Health and Prenatal Care
5/15/2012 1:24:36 PM
More...
|
IntelligentMDx to Present Development of Two CE-Marked Assays at 22nd Annual European Congress of Clinical Microbiology and Infectious Diseases
3/27/2012 2:16:11 PM
More...
|
Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch
3/6/2012 2:31:38 PM
More...
|
|